Alfasigma's $800 million buyout of Intercept Pharma two years ago is starting to look like a poor bet, as its only approved ...

In a Securities & Exchange Commission (SEC) filing (PDF), AbbVie said it had reached an agreement with "all generic ...

Vanessa Morales-Tirado, Principal Scientist -Research, AbbVie ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Amy Burroughs, CEO of Terns Pharmaceuticals, about ...

Having a continuous pulse on brand health is essential for pharmaceutical companies to inform strategic decisions and ...

The novel formulation of the stalwart chemotherapeutic drug gemcitabine, which allows it to be administered directly into the ...

Successful generative AI implementation in life sciences demands careful prioritisation and setting realistic expectations.

Generics company Zentiva is reported to be poised for a sale by current owner Advent International to US investment group ...

A report on pharma competitiveness, published by the Association of the British Pharmaceutical Industry (ABPI), claims that ...

The job of a medical science liaison is in some ways tailor-made for AI support: it’s a job all about managing massive ...

As AI continues to evolve, the life sciences industry must ensure that its transformation is inclusive, ethical, and driven ...

The compounds that emerge aren't just theoretical curiosities. They're synthesised and tested, and one targeting fibrosis ...